IMBiotechnologies is a privately held Canadian biotechnology company whose focus is commercializing medical device products in the area of embolotherapy. IMBiotechnologies' lead product is Ekobi 500 Embolization Microspheres. It is a first in class biodegradable embolic agent that is visible by ultrasound. Ekobi 500 is a medical device cleared by the FDA for the treatment of hypervascularized tumors.
View Top Employees from IMBiotechnologies Ltd| Website | http://www.imbiotechnologies.com |
| Revenue | $7 million |
| Employees | 2 (1 on RocketReach) |
| Address | 9650 20 Ave NW, Edmonton, Alberta, CA |
| Phone | (780) 945-6609 |
| Fax | (780) 987-0941 |
| Technologies |
JavaScript,
HTML,
Twitter
+3 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Medical Devices & Equipment, Manufacturing |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular IMBiotechnologies Ltd employee's phone or email?
IMBiotechnologies Ltd Questions
The IMBiotechnologies Ltd annual revenue was $7 million in 2024.
1 people are employed at IMBiotechnologies Ltd.
IMBiotechnologies Ltd is based in Edmonton, Alberta.
The NAICS codes for IMBiotechnologies Ltd are [33, 334].
The SIC codes for IMBiotechnologies Ltd are [38, 384].
Top IMBiotechnologies Ltd Employees
Related Companies
